Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Keilholz

Showing results (11-20 of 145) with videos related to

Pageof 15
Sort By:
Scandinavian Journal of Immunology|December 1, 1995
Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytesA Schmittel, C Scheibenbogen, U Keilholz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patientsC Scheibenbogen, W Hunstein, U Keilholz
Biotechniques|October 30, 1998
Internal control for quality assurance of diagnostic RT-PCRM Willhauck, S Vogel, U Keilholz
British Journal of Cancer|July 7, 2000
What can we learn from phase II adjuvant trials in melanoma?U Keilholz, S Suciu, A M Eggermont
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Quantification of tumor-specific T lymphocytes with the ELISPOT assayA Schmittel, U Keilholz, E Thiel, et al.
Aktuelle Urologie|July 2, 2011
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]K Miller, L Bergmann, J Gschwend, et al.
Annals of the Rheumatic Diseases|February 1, 1993
Rheumatic disease following immunotherapyC Scheibenbogen, U Keilholz, A Pezzutto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Neomycin as secondary prophylaxis for irinotecan-induced diarrheaA Schmittel, K Jahnke, E Thiel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanomaT M Proebstle, C Scheibenbogen, W Sterry, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1989
[Primary malignant non-Hodgkin lymphoma of the uterus]W Kühn, W Leucht, H H Rummel, et al.
Pageof 15

Showing results (11-20 of 145) with videos related to

Sort By:
Pageof 15
Scandinavian Journal of Immunology|December 1, 1995
Lipopolysaccharide effectively up-regulates B7-1 (CD80) expression and costimulatory function of human monocytesA Schmittel, C Scheibenbogen, U Keilholz
European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patientsC Scheibenbogen, W Hunstein, U Keilholz
Biotechniques|October 30, 1998
Internal control for quality assurance of diagnostic RT-PCRM Willhauck, S Vogel, U Keilholz
British Journal of Cancer|July 7, 2000
What can we learn from phase II adjuvant trials in melanoma?U Keilholz, S Suciu, A M Eggermont
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 6, 2000
Quantification of tumor-specific T lymphocytes with the ELISPOT assayA Schmittel, U Keilholz, E Thiel, et al.
Aktuelle Urologie|July 2, 2011
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma]K Miller, L Bergmann, J Gschwend, et al.
Annals of the Rheumatic Diseases|February 1, 1993
Rheumatic disease following immunotherapyC Scheibenbogen, U Keilholz, A Pezzutto, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 28, 2004
Neomycin as secondary prophylaxis for irinotecan-induced diarrheaA Schmittel, K Jahnke, E Thiel, et al.
European Journal of Cancer (Oxford, England : 1990)|August 1, 1996
A phase II study of dacarbazine, cisplatin, interferon-alpha and high-dose interleukin-2 in 'poor-risk' metastatic melanomaT M Proebstle, C Scheibenbogen, W Sterry, et al.
Geburtshilfe Und Frauenheilkunde|May 1, 1989
[Primary malignant non-Hodgkin lymphoma of the uterus]W Kühn, W Leucht, H H Rummel, et al.
Pageof 15